Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leech therapy versus gabapentin for diabetic neuropathy of the lower limbs
IRCT20150927024228N3Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of gabapentin in diabetic neuropathy (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Severity of pain, Severity of burning and 1 more. Started Aug 2020; status: completed.
02
Drugs
gabapentin
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on IRCT20150927024228N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150927024228N3.